Coeptis Therapeutics Holdings Inc.
COEP • NASDAQ
Coeptis Therapeutics Holdings Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Mehalick, with a market cap of $66.5M.
CEODavid Mehalick
Next Earnings
Upcoming earnings announcement for Coeptis Therapeutics Holdings Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (5:00 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for Coeptis Therapeutics Holdings Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.12 | — | $862.0K | — |  10-K |
| Nov 14, 2025 | Q3 2025 | -$0.58 | — | $192.3K | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$1.17 | — | $200.7K | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$1.11 | — | $62.9K | — | 10-Q |
| Mar 28, 2025 | Q4 2024 | -$5.44 | — | - | — | 10-K |
| Nov 13, 2024 | Q3 2024 | -$1.00Est: -$1.00 | 0.0% | - | — | 10-Q |
| Aug 16, 2024 | Q2 2024 | -$1.60 | — | - | — | 10-Q/A |
| May 10, 2024 | Q1 2024 | -$1.60 | — | - | — | — |
| Mar 26, 2024 | Q4 2023 | -$1.60Est: -$2.40 | +33.3% | - | — | — |
| Nov 9, 2023 | Q3 2023 | -$4.60 | — | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$2.80Est: -$4.00 | +30.0% | - | — | — |
| May 15, 2023 | Q1 2023 | -$7.80Est: -$4.00 | -95.0% | - | — | — |